Associations
newsletter
subscribe
advertise
contact
Technology
pulseTV
Buyer's Guide
Comparison Charts
Blogs
Events
Webinars
Magazine
Cardiac Diagnostics
ECG
ECG Management Systems
Holter Monitoring Systems
Stress Test Systems
Cardiac Imaging
Advanced Visualization
Angiography Systems
Cardiovascular Ultrasound
Contrast Media
CT Systems
Hybrid OR
MRI Systems
Nuclear Imaging
Cath Lab
Angiography Systems
Balloon Catheters
Hemostasis Management
Intravascular Imaging Systems
Interventional Radiology
Hybrid OR
Radial Access
Stents
Ventricular Assist Devices (VAD)
EP Lab
Ablation Systems
Cardiac Resynchronization Therapy Devices (CRT)
Implantable Cardioverter Defibrillators (ICD)
Leads, implantable devices
Pacemakers
Information Technology
Advanced Visualization
Cardiac PACS
Telecardiology
Structural Heart
Heart Valve Repair
Hybrid OR
Left Atrial Appendage (LAA) Occluders
Structural Heart Occluders/Closure Devices
Novartis Pharmaceuticals
One Health Plaza
East Hanover
NJ
07936-1080
USA
Phone:
(888) 669-6682
http://www.pharma.us.novartis.com
Product Categories: Taxo=pharmaceuticals&Taxo=diagnostic_and_interventional_cardiology_daic
Related Articles
Remote Monitoring
Health 2.0 Launches CardioEngagement Developer Challenge
Heart Failure Treatments
Health 2.0 Launches CardioEngagement Developer Challenge
Telecardiology
Health 2.0 Launches CardioEngagement Developer Challenge
Pharmaceuticals
FDA Approves Generic Version of Blood Pressure Medication
Hypertension Drug With Less-Frequent Dosing May Gain Market Share
FDA Clears Valturna, Single-Pill Combination of Valsartan, Aliskiren, for High Blood Pressure
FDA Approves Tekturna HCT to Treat Patients With High Blood Pressure
FDA Approves Drug for High Blood Pressure
Hypertension Therapies
FDA Approves Generic Version of Blood Pressure Medication
Hypertension Drug With Less-Frequent Dosing May Gain Market Share
FDA Approves Drug for High Blood Pressure
General Cardiology
FDA Approves Drug for High Blood Pressure
